18 Surgery for heart failure: experiences from severance cardiovascular hospital, seoul, korea

Q2 Medicine
Jung-Hwan Kim
{"title":"18 Surgery for heart failure: experiences from severance cardiovascular hospital, seoul, korea","authors":"Jung-Hwan Kim","doi":"10.1136/HEARTASIA-2019-APAHFF.18","DOIUrl":null,"url":null,"abstract":"Since the first successful heart transplant in Korea in 1992, the case volume has been rapidly increasing. Compared with ISHLT registry data, the Korean KONOS registry data show similar post-transplant long-term survival rates. At Severance Cardiovascular Hospital (SCH) of Yonsei University, the number of heart transplants has been growing steadily since 2010. Between 1994 and 2018, 174 heart transplantations had been performed. Mean age of recipients and their follow-up duration were 42.9 and 3.2 years, respectively. Pre-operative CPR was performed in 18 (10.3%) patients, and extracorporeal membrane oxygenation (ECMO) was applied in 35 (20.1%) patients. In-hospital mortality was 19% and 10 year survival rate was 71.7%. By multivariate analysis, risk factors for in-hospital mortality were pre-operative elevated bilirubin and lactate levels. Risk factors for overall mortality were pre-operative dialysis, and high bilirubin and lactate levels. Gender and pre-operative body weight mismatch and ECMO bridging were not independent risk factors for mortality. The volume of LVAD implants had been low in Korea due to reimbursement limitations. However, from October 2018, a new national insurance policy was implemented to provide for 95% of total device cost. This change is projected to increase device implant rates and patient access. In conclusion, size-mismatch did not affect LVAD outcomes for the East Asian population. Organ protection remains an important factor for long-term survival. In the short term, MCS including ECMO may be used to reverse organ dysfunction as a bridge to recovery or decision. Finally, LVAD will be a main strategy for bridge-to-transplant (BTT) in Korea.","PeriodicalId":12858,"journal":{"name":"Heart Asia","volume":"11 1","pages":"A8 - A8"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/HEARTASIA-2019-APAHFF.18","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/HEARTASIA-2019-APAHFF.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Since the first successful heart transplant in Korea in 1992, the case volume has been rapidly increasing. Compared with ISHLT registry data, the Korean KONOS registry data show similar post-transplant long-term survival rates. At Severance Cardiovascular Hospital (SCH) of Yonsei University, the number of heart transplants has been growing steadily since 2010. Between 1994 and 2018, 174 heart transplantations had been performed. Mean age of recipients and their follow-up duration were 42.9 and 3.2 years, respectively. Pre-operative CPR was performed in 18 (10.3%) patients, and extracorporeal membrane oxygenation (ECMO) was applied in 35 (20.1%) patients. In-hospital mortality was 19% and 10 year survival rate was 71.7%. By multivariate analysis, risk factors for in-hospital mortality were pre-operative elevated bilirubin and lactate levels. Risk factors for overall mortality were pre-operative dialysis, and high bilirubin and lactate levels. Gender and pre-operative body weight mismatch and ECMO bridging were not independent risk factors for mortality. The volume of LVAD implants had been low in Korea due to reimbursement limitations. However, from October 2018, a new national insurance policy was implemented to provide for 95% of total device cost. This change is projected to increase device implant rates and patient access. In conclusion, size-mismatch did not affect LVAD outcomes for the East Asian population. Organ protection remains an important factor for long-term survival. In the short term, MCS including ECMO may be used to reverse organ dysfunction as a bridge to recovery or decision. Finally, LVAD will be a main strategy for bridge-to-transplant (BTT) in Korea.
心力衰竭的手术治疗:首尔severance心血管医院的经验
自1992年国内首例心脏移植手术成功后,患者数量迅速增加。与ISHLT登记数据相比,韩国KONOS登记数据显示相似的移植后长期生存率。延世大学Severance心血管医院(SCH)的心脏移植手术从2010年开始持续增加。1994年至2018年期间,进行了174例心脏移植手术。受试者的平均年龄为42.9岁,随访时间为3.2岁。术前行心肺复苏术18例(10.3%),体外膜氧合35例(20.1%)。住院死亡率为19%,10年生存率为71.7%。通过多因素分析,术前胆红素和乳酸水平升高是院内死亡的危险因素。总死亡率的危险因素是术前透析、高胆红素和乳酸水平。性别、术前体重不匹配和ECMO桥接不是死亡率的独立危险因素。由于报销限制,LVAD植入物的数量在韩国一直很低。然而,从2018年10月开始,实施了一项新的国家保险政策,提供95%的设备总成本。这一变化预计将增加设备植入率和患者访问。总之,尺寸不匹配并不影响东亚人群LVAD的结果。器官保护仍然是长期生存的重要因素。短期内,包括ECMO在内的MCS可用于逆转器官功能障碍,作为恢复或决定的桥梁。最后,LVAD将成为韩国移植桥(BTT)的主要战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart Asia
Heart Asia Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信